Quantitative proteomic analysis reveals induction of premature senescence in human umbilical vein endothelial cells exposed to chronic low-dose rate gamma radiation

Proteomics

Volumn 13, Issue 7, 2013, Pages 1096-1107

  Yentrapalli, Ramesh ^a,b   Azimzadeh, Omid ^a   Barjaktarovic, Zarko ^a   Sarioglu, Hakan ^a   Wojcik, Andrzej ^b   Harms Ringdahl, Mats ^b   Atkinson, Michael J ^a,c   Haghdoost, Siamak ^b   Tapio, Soile ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cell biology; Endothelium; ICPL; Ionizing radiation; Senescence

Indexed keywords

CELL PROTEIN; PROTEIN P21; PROTEIN P53;

ARTICLE; BLOOD VESSEL INJURY; CELL ADHESION; CELL COMMUNICATION; CELL DIVISION; CONTROLLED STUDY; DNA DAMAGE; ENDOTHELIUM CELL; GAMMA RADIATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VIVO STUDY; IONIZING RADIATION; LONG TERM EXPOSURE; OXIDATIVE STRESS; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RADIATION EXPOSURE; SENESCENCE; UMBILICAL VEIN ENDOTHELIAL CELL;

CELL AGING; CELL PROLIFERATION; CELL SHAPE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOSE-RESPONSE RELATIONSHIP, RADIATION; GAMMA RAYS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOBLOTTING; METABOLIC NETWORKS AND PATHWAYS; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84875909224     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201200463     Document Type: Article

References (64)

1. Ivanov, V. K., Maksioutov, M. A., Chekin, S. Y., Petrov, A. V. et al., The risk of radiation-induced cerebrovascular disease in Chernobyl emergency workers. Health Phys. 2006, 90, 199-207.
2. Ivanov, V. K., Late cancer and noncancer risks among Chernobyl emergency workers of Russia. Health Phys. 2007, 93, 470-479.
3. McGeoghegan, D., Binks, K., Gillies, M., Jones, S. et al., The non-cancer mortality experience of male workers at British Nuclear Fuels plc, 1946-2005. Int. J. Epidemiol. 2008, 37, 506-518.
4. Ashmore, J. P., Krewski, D., Zielinski, J. M., Jiang, H. et al., First analysis of mortality and occupational radiation exposure based on the National Dose Registry of Canada. Am. J. Epidemiol. 1998, 148, 564-574.
5. Howe, G. R., Zablotska, L. B., Fix, J. J., Egel, J. et al., Analysis of the mortality experience amongst U.S. nuclear power industry workers after chronic low-dose exposure to ionizing radiation. Radiat. Res. 2004, 162, 517-526.
6. Azizova, T. V., Muirhead, C. R., Druzhinina, M. B., Grigoryeva, E. S. et al., Cardiovascular diseases in the cohort of workers first employed at Mayak PA in 1948-1958. Radiat. Res. 2010, 174, 155-168.
7. Luscher, T. F., Richard, V., Tschudi, M., Yang, Z. H. et al., Endothelial control of vascular tone in large and small coronary arteries. J. Am. Coll. Cardiol. 1990, 15, 519-527.
8. Furchgott, R. F., Zawadzki, J. V., The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980, 288, 373-376.
9. Herrera, M. D., Mingorance, C., Rodriguez-Rodriguez, R., Sotomayor, M. A., Endothelial dysfunction and aging: an update. Ageing Res. Rev. 2010, 9, 142-152.
10. Bilato, C., Crow, M. T., Atherosclerosis and the vascular biology of aging. Aging 1996, 8, 221-234.
11. Stewart, F. A., Heeneman, S., Te Poele, J., Kruse, J. et al., Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE-/- mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage. Am. J. Pathol. 2006, 168, 649-658.
12. Mitchel, R. E., Hasu, M., Bugden, M., Wyatt, H. et al., Low-dose radiation exposure and atherosclerosis in ApoE(-)/(-) mice. Radiat. Res. 2011, 175, 665-676.
13. Minamino, T., Miyauchi, H., Yoshida, T., Ishida, Y. et al., Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 2002, 105, 1541-1544.
14. Merat, S., Fruebis, J., Sutphin, M., Silvestre, M. et al., Effect of aging on aortic expression of the vascular cell adhesion molecule-1 and atherosclerosis in murine models of atherosclerosis. J. Gerontol. A Biol. Sci. Med. Sci. 2000, 55, B85-B94.
15. Chang, E., Harley, C. B., Telomere length and replicative aging in human vascular tissues. Proc. Natl. Acad. Sci. USA 1995, 92, 11190-11194.
16. Suzuki, K., Mori, I., Nakayama, Y., Miyakoda, M. et al., Radiation-induced senescence-like growth arrest requires TP53 function but not telomere shortening. Radiat. Res. 2001, 155, 248-253.
17. Marcotte, R., Wang, E., Replicative senescence revisited. J. Gerontol. A Biol. Sci. Med. Sci. 2002, 57, B257-B269.
18. Wood, M. A., Cavender, J. F., Beta-galactosidase staining as a marker of cells enduring stress. BIOS 2004, 75, 139-146.
19. Imaizumi, N., Monnier, Y., Hegi, M., Mirimanoff, R. O. et al., Radiotherapy suppresses angiogenesis in mice through TGF-betaRI/ALK5-dependent inhibition of endothelial cell sprouting. PLoS ONE 2010, 5, e11084.
20. Laemmli, U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
21. Chaerkady, R., Letzen, B., Renuse, S., Sahasrabuddhe, N. A. et al., Quantitative temporal proteomic analysis of human embryonic stem cell differentiation into oligodendrocyte progenitor cells. Proteomics 2011, 11, 4007-4020.
22. Shao, H., Chaerkady, R., Chen, S., Pinto, S. M. et al., Proteome profiling of wild type and lumican-deficient mouse corneas. J. Proteomics 2011, 74, 1895-1905.
23. Azimzadeh, O., Scherthan, H., Sarioglu, H., Barjaktarovic, Z. et al., Rapid proteomic remodeling of cardiac tissue caused by total body ionizing radiation. Proteomics 2011, 11, 3299-3311.
24. Sarioglu, H., Brandner, S., Jacobsen, C., Meindl, T. et al., Quantitative analysis of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-induced proteome alterations in 5L rat hepatoma cells using isotope-coded protein labels. Proteomics 2006, 6, 2407-2421.
25. Blagoev, B., Kratchmarova, I., Ong, S. E., Nielsen, M. et al., A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat. Biotechnol. 2003, 21, 315-318.
26. Mann, M., Kelleher, N. L., Precision proteomics: the case for high resolution and high mass accuracy. Proc. Natl. Acad. Sci. USA 2008, 105, 18132-18138.
27. Mayburd, A. L., Martlinez, A., Sackett, D., Liu, H. et al., Ingenuity network-assisted transcription profiling: identification of a new pharmacologic mechanism for MK886. Clin. Cancer Res. 2006, 12, 1820-1827.
28. Leroy, B., Rosier, C., Erculisse, V., Leys, N. et al., Differential proteomic analysis using isotope-coded protein-labeling strategies: comparison, improvements and application to simulated microgravity effect on Cupriavidus metallidurans CH34. Proteomics 2010, 10, 2281-2291.
29. Martins-de-Souza, D., Gattaz, W. F., Schmitt, A., Rewerts, C. et al., Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 2009, 259, 151-163.
30. Martins-de-Souza, D., Gattaz, W. F., Schmitt, A., Rewerts, C. et al., Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis. J. Neural. Transm. 2009, 116, 275-289.
31. Miyauchi, H., Minamino, T., Tateno, K., Kunieda, T. et al., Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway. EMBO J. 2004, 23, 212-220.
32. Shelton, D. N., Chang, E., Whittier, P. S., Choi, D. et al., Microarray analysis of replicative senescence. Curr. Biol. 1999, 9, 939-945.
33. Sugihara, T., Murano, H., Nakamura, M., Ichinohe, K. et al., p53-Mediated gene activation in mice at high doses of chronic low-dose-rate gamma radiation. Radiat. Res. 2011, 175, 328-335.
34. Boehme, K. A., Kulikov, R., Blattner, C., p53 stabilization in response to DNA damage requires Akt/PKB and DNA-PK. Proc. Natl. Acad. Sci. USA 2008, 105, 7785-7790.
35. Levine, A. J., Hu, W., Feng, Z., The P53 pathway: what questions remain to be explored? Cell Death Differ. 2006, 13, 1027-1036.
36. Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S. et al., p53 mutant mice that display early ageing-associated phenotypes. Nature 2002, 415, 45-53.
37. Maier, B., Gluba, W., Bernier, B., Turner, T. et al., Modulation of mammalian life span by the short isoform of p53. Genes Dev. 2004, 18, 306-319.
38. Das, S. K., Sharma, N. K., Hasstedt, S. J., Mondal, A. K. et al., An integrative genomics approach identifies activation of thioredoxin/thioredoxin reductase-1-mediated oxidative stress defense pathway and inhibition of angiogenesis in obese nondiabetic human subjects. J. Clin. Endocrinol. Metab. 2011, 96, E1308-E1313.
39. Ding, Z., Lambrechts, A., Parepally, M., Roy, P., Silencing profilin-1 inhibits endothelial cell proliferation, migration and cord morphogenesis. J. Cell Sci. 2006, 119, 4127-4137.
40. Sakai, K., Oka, K., Matsumoto, K., Nakamura, T., p27 nuclear localization and growth arrest caused by perlecan knockdown in human endothelial cells. Biochem. Biophys. Res. Commun. 2010, 392, 403-408.
41. Liau, S. S., Rocha, F., Matros, E., Redston, M. et al., High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma. Cancer 2008, 113, 302-314.
42. Kim, J., Koyanagi, T., Mochly-Rosen, D., PKCdelta activation mediates angiogenesis via NADPH oxidase activity in PC-3 prostate cancer cells. Prostate 2011, 71, 946-954.
43. Chesney, J., Metz, C., Bacher, M., Peng, T. et al., An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol. Med. 1999, 5, 181-191.
44. Nishihira, J., Ishibashi, T., Fukushima, T., Sun, B. et al., Macrophage migration inhibitory factor (MIF): its potential role in tumor growth and tumor-associated angiogenesis. Ann. NY Acad. Sci. 2003, 995, 171-182.
45. Mitchell, R. A., Mechanisms and effectors of MIF-dependent promotion of tumourigenesis. Cell Signal 2004, 16, 13-19.
46. Xu, X., Wang, B., Ye, C., Yao, C. et al., Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer. Cancer Lett. 2008, 261, 147-157.
47. Rho, J. H., Roehrl, M. H., Wang, J. Y., Tissue proteomics reveals differential and compartment-specific expression of the homologs transgelin and transgelin-2 in lung adenocarcinoma and its stroma. J. Proteome Res. 2009, 8, 5610-5618.
48. Ivaska, J., Pallari, H. M., Nevo, J., Eriksson, J. E., Novel functions of vimentin in cell adhesion, migration, and signaling. Exp. Cell Res. 2007, 313, 2050-2062.
49. Yang, F., Waters, K. M., Miller, J. H., Gritsenko, M. A. et al., Phosphoproteomics profiling of human skin fibroblast cells reveals pathways and proteins affected by low doses of ionizing radiation. PLoS ONE 2010, 5, e14152.
50. Brown, M. J., Nijhara, R., Hallam, J. A., Gignac, M. et al., Chemokine stimulation of human peripheral blood T lymphocytes induces rapid dephosphorylation of ERM proteins, which facilitates loss of microvilli and polarization. Blood 2003, 102, 3890-3899.
51. Liu, Y., Belkina, N. V., Park, C., Nambiar, R. et al., Constitutively active ezrin increases membrane tension, slows migration, and impedes endothelial transmigration of lymphocytes in vivo in mice. Blood 2012, 119, 445-453.
52. Yang, H. S., Hinds, P. W., Phosphorylation of ezrin by cyclin-dependent kinase 5 induces the release of Rho GDP dissociation inhibitor to inhibit Rac1 activity in senescent cells. Cancer Res. 2006, 66, 2708-2715.
53. Mori, T., Kitano, K., Terawaki, S., Maesaki, R. et al., Structural basis for CD44 recognition by ERM proteins. J. Biol. Chem. 2008, 283, 29602-29612.
54. Kondoh, H., Lleonart, M. E., Gil, J., Wang, J. et al., Glycolytic enzymes can modulate cellular life span. Cancer Res. 2005, 65, 177-185.
55. Lii, C. K., Lin, A. H., Lee, S. L., Chen, H. W. et al., Oxidative modifications of proteins by sodium arsenite in human umbilical vein endothelial cells. Environ. Toxicol. 2011, 26, 459-471.
56. Kamino, H., Hiratsuka, M., Toda, T., Nishigaki, R. et al., Searching for genes involved in arteriosclerosis: proteomic analysis of cultured human umbilical vein endothelial cells undergoing replicative senescence. Cell Struct. Funct. 2003, 28, 495-503.
57. Eman, M. R., Regan-Klapisz, E., Pinkse, M. W., Koop, I. M. et al., Protein expression dynamics during replicative senescence of endothelial cells studied by 2-D difference in-gel electrophoresis. Electrophoresis 2006, 27, 1669-1682.
58. Chang, M. W., Grillari, J., Mayrhofer, C., Fortschegger, K. et al., Comparison of early passage, senescent and hTERT immortalized endothelial cells. Exp. Cell Res. 2005, 309, 121-136.
59. Mun, G. I., Boo, Y. C., Identification of CD44 as a senescence-induced cell adhesion gene responsible for the enhanced monocyte recruitment to senescent endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2010, 298, H2102-H2111.
60. Grillari, J., Hohenwarter, O., Grabherr, R. M., Katinger, H., Subtractive hybridization of mRNA from early passage and senescent endothelial cells. Exp. Gerontol. 2000, 35, 187-197.
61. Schneiderman, J., Sawdey, M. S., Keeton, M. R., Bordin, G. M. et al., Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc. Natl. Acad. Sci. USA 1992, 89, 6998-7002.
62. Comi, P., Chiaramonte, R., Maier, J. A., Senescence-dependent regulation of type 1 plasminogen activator inhibitor in human vascular endothelial cells. Exp. Cell Res. 1995, 219, 304-308.
63. Sriharshan, A., Boldt, K., Sarioglu, H., Barjaktarovic, Z. et al., Proteomic analysis by SILAC and 2D-DIGE reveals radiation-induced endothelial response: four key pathways. J. Proteomics 2012, 75, 2319-2330.
64. Barjaktarovic, Z., Schmaltz, D., Shyla, A., Azimzadeh, O. et al., Radiation-induced signaling results in mitochondrial impairment in mouse heart at 4 weeks after exposure to X-rays. PLoS ONE 2011, 6, e27811.